Status: Improving
Most Recent Data:
0.6
cases of acute hepatitis B per 100,000 population
(2021)
Target:
0.1
per 100,000
Desired Direction:
Decrease desired
Baseline:
1.1
cases of acute hepatitis B per 100,000 population were reported in 2017
Reduce the rate of acute hepatitis B
Data Sources: National Notifiable Diseases Surveillance System (NNDSS), CDC/CSELS; Bridged-race Population Estimates, CDC/NCHS and Census
Summary
Thousands of people get acute hepatitis B in the United States every year. While the infection can go away, some people develop a lifelong infection and are at increased risk for liver disease, cirrhosis, and liver cancer. Making sure all infants, children, and at-risk adults get the hepatitis B vaccine can help reduce the rate of acute hepatitis B nationwide.
